Patent · US Active

Epinephrine spray formulations

US10617637B2 · kind B2 · utility

0Cited by
1References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 29, 2018
Grant dateApr 14, 2020
Priority date
Expiry dateJun 29, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M11/001
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to epinephrine spray formulations. The present invention is further directed to methods of treating anaphylaxis by administering epinephrine spray formulations to subjects in need of such treatments.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.